Article
Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa.
Antimicrobial agents and chemotherapy - 21 Apr 2020
McCormick Kevin D, Penrose Kerri J, Brumme Chanson J, Harrigan P Richard, Viana Raquel V, Mellors John W, Parikh Urvi M, Wallis Carole L
Abstract excerpt
Etravirine (ETR) is a nonnucleoside reverse transcriptase inhibitor (NNRTI) used in treatment-experienced individuals. Genotypic resistance test-interpretation systems can predict ETR resistance; however, genotype-based algorithms are derived primarily from HIV-1 subtype B and may not accurately predict resistance in non-B subtypes. The frequency of ETR resistance among recombinant subtype C HIV-1 and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
